Načítá se...
Depression Levels and Interferon Treatment in People with Multiple Sclerosis
Multiple sclerosis (MS) is the most common cause of neurologic disease in young and middle-aged adults, and 75% of patients are female. Nearly one in two patients with MS will experience clinically significant depression—approximately three times the prevalence rate in the general population. This s...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
The Consortium of Multiple Sclerosis Centers
2012
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3882981/ https://ncbi.nlm.nih.gov/pubmed/24453727 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7224/1537-2073-14.1.10 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|